review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Rosalind L Smyth | |
Clare Halfhide | |||
P2860 | cites work | Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells | Q24681094 |
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 | ||
When a "wheeze" is not a wheeze: acoustic analysis of breath sounds in infants | Q30539369 | ||
The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature | Q33298578 | ||
Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study | Q33699961 | ||
Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. | Q33737766 | ||
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus | Q33848810 | ||
Surfactant protein-A enhances respiratory syncytial virus clearance in vivo | Q33848860 | ||
Risk of primary infection and reinfection with respiratory syncytial virus | Q34188122 | ||
Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production | Q35023969 | ||
Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis | Q35046676 | ||
Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches | Q35097207 | ||
The Childhood Origins of Asthma (COAST) study | Q35104581 | ||
Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. | Q35274231 | ||
Surfactant protein levels in severe respiratory syncytial virus infection | Q45750254 | ||
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection | Q45819346 | ||
Rhinovirus illnesses during infancy predict subsequent childhood wheezing | Q47729174 | ||
A comparison of risk factors for wheeze and recurrent cough in preschool children | Q47764696 | ||
Characterization of wheezing phenotypes in the first 10 years of life | Q47906199 | ||
Wheeze phenotypes and lung function in preschool children | Q47907457 | ||
Risk factor associations with wheezing patterns in children followed longitudinally from birth to 3(1/2) years. | Q51728966 | ||
Household chemicals, persistent wheezing and lung function: effect modification by atopy? | Q51974232 | ||
Bronchiolitis | Q56287325 | ||
Association between antenatal cytokine production and the development of atopy and asthma at age 6 years | Q57297451 | ||
Integrin β3 genotype influences asthma and allergy phenotypes in the first 6 years of life | Q57307938 | ||
Sex-related differences in immune development and the expression of atopy in early childhood | Q64461539 | ||
Asthma and wheezing in the first six years of life. The Group Health Medical Associates | Q72356528 | ||
High-frequency respiratory impedance measured by forced-oscillation technique in infants | Q77074065 | ||
Epidemiological and clinical features of hMPV, RSV and RVs infections in young children | Q79621096 | ||
Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: subgroup analysis of the 20-year prospective follow-up study | Q80183754 | ||
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families | Q35533594 | ||
Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000 | Q35537316 | ||
Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood | Q35563236 | ||
High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis | Q36184072 | ||
IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus | Q36389523 | ||
Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development | Q36540154 | ||
Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review | Q36543167 | ||
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children | Q36903511 | ||
Newly discovered respiratory viruses: significance and implications | Q36906083 | ||
Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response | Q39612134 | ||
Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism | Q40290650 | ||
Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection | Q40327306 | ||
Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. | Q40964896 | ||
Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium | Q41031812 | ||
The relationship of childhood respiratory illness to adult obstructive airway disease | Q41052711 | ||
Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin | Q41105440 | ||
Respiratory syncytial virus genotypes and disease severity among children in hospital | Q42143633 | ||
Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children | Q42551496 | ||
Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus | Q42723106 | ||
The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children | Q43410750 | ||
Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study | Q43449612 | ||
Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants | Q43545609 | ||
Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection | Q43975928 | ||
Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection | Q44007532 | ||
Rhinovirus replication causes RANTES production in primary bronchial epithelial cells | Q44654227 | ||
Respiratory morbidity 20 years after RSV infection in infancy | Q44947702 | ||
Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy | Q45307654 | ||
Activation of the granzyme pathway in children with severe respiratory syncytial virus infection | Q45396723 | ||
Expression of chemokine receptor CX3CR1 in infants with respiratory syncytial virus bronchiolitis | Q45397301 | ||
Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. | Q45401032 | ||
Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice | Q45401178 | ||
Impact of human metapneumovirus and respiratory syncytial virus co-infection in severe bronchiolitis | Q45402651 | ||
Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells | Q45423182 | ||
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. | Q45496193 | ||
Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. | Q45528390 | ||
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. | Q45556830 | ||
Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease | Q45640302 | ||
Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis | Q45658252 | ||
Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis | Q45697921 | ||
Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. | Q45719599 | ||
Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus | Q45721882 | ||
Impact of severe disease caused by respiratory syncytial virus in children living in developed countries | Q45728493 | ||
Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways | Q45730326 | ||
Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype | Q45732918 | ||
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo | Q45746389 | ||
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years | Q45747463 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bronchiolitis | Q424227 |
wheeze | Q517104 | ||
P304 | page(s) | 251-262 | |
P577 | publication date | 2008-10-23 | |
P1433 | published in | Paediatric Respiratory Reviews | Q15759971 |
P1476 | title | Innate immune response and bronchiolitis and preschool recurrent wheeze | |
P478 | volume | 9 |
Q36698136 | A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children |
Q37683975 | Acute viral bronchiolitis in children- a very common condition with few therapeutic options |
Q24197565 | Antibiotics for persistent cough or wheeze following acute bronchiolitis in children |
Q24202367 | Antibiotics for persistent cough or wheeze following acute bronchiolitis in children |
Q38614685 | Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. |
Q42263185 | Blood eosinophil counts during bronchiolitis are related to bronchial hyper-responsiveness and lung function in early adolescence |
Q34282702 | Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection |
Q40047684 | Environmental factors association between asthma and acute bronchiolitis in young children--a perspective cohort study |
Q34409774 | Genetic polymorphisms and risk of recurrent wheezing in pediatric age |
Q24202303 | Glucocorticoids for acute viral bronchiolitis in infants and young children |
Q24234702 | Glucocorticoids for acute viral bronchiolitis in infants and young children |
Q42245332 | Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis |
Q24187257 | Leukotriene inhibitors for bronchiolitis in infants and young children |
Q24201695 | Leukotriene inhibitors for bronchiolitis in infants and young children |
Q42270216 | Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort. |
Q24202237 | Systemic steroids versus placebo for acute wheeze in preschool aged children |
Q37760564 | Viral bronchiolitis for the clinician |